24. December 2017

Dissolution testing is an important tool from early development to life cycle management of a drug product. With the aim to give an update on the application of dissolution testing in assessing critical formulation attributes with regard to bioavailability of the respective drug product, on September 26-27, 2017, on the initiative of Dr. Horst-Dieter Friedel who is co- chair of the International Pharmaceutical Federation (FIP) Focus Group